What You Should Know:
- ActiGraph, a global leader in wearable digital health technology, announced the acquisition of Biofourmis Connect, a division of Biofourmis specializing in AI-powered digital trial platforms for the life science industry. Financial terms of the acquisition were not disclosed.
- The acquisition combines ActiGraph's expertise in wearable technology with Biofourmis Connect's advanced analytics capabilities, creating a comprehensive and unified solution for
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
M&A: Predictive Oncology to be Acquired by Renovaro
What You Should Know:
- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced its upcoming acquisition by Renovaro, Inc. (NASDAQ: RENB) in a strategic move aimed at accelerating innovation and improving cancer treatment outcomes.
- The merger brings together two companies with a shared commitment to leveraging artificial intelligence and machine learning to transform cancer care.
Synergistic Strengths and Shared Vision
Both Predictive
Read More
Funding Challenges for Innovation in MedTech in 2025
In the MedTech sector, small and medium-sized organizations are the primary drivers of innovation, developing new technologies for diagnosing, monitoring, and treating various conditions. Despite their potential to transform patient care and enhance efficiency in healthcare environments, these companies face significant funding challenges. The high costs of development, complex regulatory pathways, and intense market competition create substantial barriers to attracting investors.
MedTech
Read More
How Digital Twins Open The Door for Next-Gen Clinical Trials
Clinical trials have been the cornerstone of medical innovation for centuries, but as the effort continues to improve patient care and speed the development of new treatments and medicines, sticking with the same old trial processes is no longer an option.
Innovative technologies like digital twins and generative AI are transforming the healthcare landscape and expanding what’s possible for the future of medicine with next-gen clinical trials.
Beyond benefits associated with
Read More
Personalis Secures $50M from Merck, Extends Collaboration with Moderna
What You Should Know:
- Personalis, Inc. (NASDAQ: PSNL) today announced agreements with long-time collaborators Merck and Moderna that accelerate the advancement of the company’s business strategy.
- The company has received a $50M investment from Merck, known as MSD outside the United States and Canada, and separately has signed a multi-year extension with Moderna to utilize Personalis’ ImmunoID NeXT Platform® and technology for V940/mRNA-4157, an investigational
Read More
eClinical Solutions & Snowflake Integrate Clinical Data Management
What You Should Know:
- eClinical Solutions LLC, a global leader in digital clinical software and services, has announced a strategic collaboration with Snowflake, the AI Data Cloud company.
- This partnership establishes a bidirectional integration designed to address the growing challenges in managing clinical data while enabling life sciences organizations to unlock greater value through a modern clinical data architecture.
eClinical Solutions Partners with Snowflake to Enhance
Read More
BrightInsight, Sanofi to Build Drug Companion Apps for its Major Specialty Therapies
What You Should Know:
- BrightInsight, Inc., a provider of regulated digital health solutions, has announced an expanded multi-year partnership with Sanofi, a global biopharmaceutical company. This expanded partnership builds on a successful collaboration that began in 2022 when Sanofi selected the BrightInsight Platform to accelerate the development of a SaMD for one of its specialty care medicines.
- The goal of the collaboration aims to accelerate Sanofi's drug development timeline and
Read More
The Role of AI in Streamlining Cannabis Dosage Recommendations
The use of medical cannabis is gaining traction for managing a wide range of conditions, from pain to stress. However, determining the right dosage remains a significant challenge.
Factors such as individual metabolism, tolerance levels, and body composition can influence how product potency affects individuals. While you can use these factors to make an educated guess on dosage, pinpointing the ideal potency level often takes experimentation.
However, artificial intelligence
Read More
Promise Bio Secures $8.3M for Auto-Immune Precision Medicine Platform
What You Should Know:
- Promise Bio, a startup transforming immune-mediated disease treatment with advanced precision medicine solutions, today announced its emergence from stealth with an $8.3 million seed investment.
- This funding will accelerate the development of Promise Bio's computational platform, which uses epiproteomics and artificial intelligence to predict patient treatment responses and support drug research and development.
Revolutionizing Immune-Mediated Disease
Read More
Pleno Closes $25M Series B & Appoints Dr. Vik Vaz as CEO
What You Should Know:
- Pleno, an innovative multi-omics diagnostics company, announced it has raised $25M in Series B funding and appointed Dr. Vik Vaz as its new Chief Executive Officer (CEO). Key investors Deerfield Management, Foresite Capital and Medical Excellence Capital remain committed to supporting the next phase of the company’s growth strategy.
- Dr. Vaz, a seasoned leader with extensive experience in the life sciences and medical technology sectors, will guide
Read More
